Skip to main content

What the FDA labels say about taking them together

Fentanyl and lenacapavir

Lenacapavir's FDA label of August 27, 2026 names fentanyl in its drug interactions section; the fentanyl labels PlainMeds reads (2) do not name lenacapavir. The lenacapavir label: “Careful monitoring of therapeutic effects and adverse reactions associated with CYP3A-metabolized narcotic analgesics is recommended with co-administration.”

Check it at the source: the fentanyl FDA label on DailyMed (effective March 6, 2026, Hikma Pharmaceuticals USA Inc.); the lenacapavir FDA label on DailyMed (effective August 27, 2026, Gilead Sciences, Inc.).

What does the fentanyl label say about lenacapavir?

Fentanyl's label (effective March 6, 2026) and its 1 other brand-application label do not name lenacapavir in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Fentanyl Citrate), Hikma Pharmaceuticals USA Inc., effective March 6, 2026 (SPL set ce5db1c2-feb1-4ad2-847a-d02e865bd47e), via openFDA; the full label on DailyMed

What does the lenacapavir label say about fentanyl?

Lenacapavir label, drug interactions

Concomitant Drug Class/Drug Name: Narcotic analgesics metabolized by CYP3A: e.g., fentanyl, oxycodone; Effect on Concentration ↑ = Increase, ↓ = Decrease.: ↑ fentanyl ↑ oxycodone; Clinical Comment: Careful monitoring of therapeutic effects and adverse reactions associated with CYP3A-metabolized narcotic analgesics (including potentially fatal respiratory depression) is recommended with co-administration.

Source: FDA drug label (Sunlenca), Gilead Sciences, Inc., effective August 27, 2026 (SPL set e5652804-29c4-40d7-aeb2-0142ed2a7b5b), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

6Fentanyl generic labelers
0Lenacapavir generic labelers
FentanylLenacapavir
Labeled forPainHIV
Boxed warningYesNo
Pharmacy cost (NADAC)$1.79 per mL 100 mcg/2 mL vialn/a
Shortage nowIn shortageNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?